🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Small Molecules

Benchmark revenue and EBITDA valuation multiples for public comps like Sinopep, Brightgene Bio-medical, Star Lake Bioscience, Betta Pharmaceuticals and Aurisco Pharmaceutical.

Small Molecules

See analyst estimates and all valuation multiples for Small Molecules
Company EV EV/LTM Revenue EV/LTM EBITDA
$4.6B 25.8x 78.3x
$3.8B 8.3x 21.5x
$3.5B 33.8x -44.5x
$3.2B 122.1x -92.6x
$2.7B 3.4x 18.1x
$2.2B 11.8x -7.1x
$2.0B 7.1x 17.9x
$1.9B 0.8x 5.5x
$1.3B 5.9x 28.3x
$1.3B 5.5x 15.9x
$980M n/a n/a
$930M n/a n/a
$893M 4.4x 18.3x
$760M 3.3x 34.2x
$671M 7.6x 21.5x
$585M 78.0x -3.2x
$498M 6.1x n/a
$322M 1.7x 5.9x
$251M 3.3x -3.5x
$210M 5.8x n/a
$171M 6.2x -7.2x
$136M n/a -6.1x
$131M 1.3x -17.2x
$129M n/a n/a
$118M n/a -25.3x
$79.3M n/a -0.6x
$78.7M 0.8x -1.9x
$51.7M 1.4x n/a
$14.4M n/a -0.1x
$4.1M 0.1x -0.0x
-$30.7M n/a n/a
-$34.9M -10.9x n/a
-$190M -6.2x 0.8x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Small Molecules

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.